Literature DB >> 21412832

Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.

Emma C Schofield1, John R Hodges, Virginia Macdonald, Nicholas J Cordato, Jillian J Kril, Glenda M Halliday.   

Abstract

To determine whether brain atrophy differs between the two subtypes of progressive supranuclear palsy (PSP), Richardson's syndrome (PSP-RS), and PSP parkinsonism (PSP-P), and whether such atrophy directly relates to clinical deficits and the severity of tau deposition. We compared 24 pathologically confirmed PSP cases (17 PSP-RS and 7 PSP-P) with 22 controls from a Sydney brain donor program. Volume loss was analyzed in 29 anatomically discrete brain regions using a validated point-counting technique, and tau-immunoreactive neurons, astrocytes and oligodendrocytes/threads semiquantified. Correlations between the two pathological measures and the presence or absence of cardinal PSP symptoms were investigated. Cortical atrophy was more severe in PSP-RS than PSP-P and affected more frontal lobe regions (frontal pole, inferior frontal gyrus). The supramarginal gyrus was atrophic in both subtypes. Additionally, atrophy of the internal globus pallidus, amygdala, and thalamus was more severe in PSP-RS. As expected, more severe frontal lobe tau pathology differentiated PSP-RS from PSP-P. No correlations were found between the degree of atrophy and severity of tau pathology in any region assessed, or between the severity of atrophy or tau pathology and the presence or absence of cardinal PSP symptoms. Our study shows that thalamocortical atrophy is a defining feature of PSP-RS, but this atrophy does not correlate with the presence of any specific cardinal clinical feature. Interestingly, there is a disassociation between tau pathology and atrophy in the brain regions affected in PSP-RS that requires further investigation.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 21412832     DOI: 10.1002/mds.23295

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

1.  The relationship between clinical and pathological variables in Richardson's syndrome.

Authors:  Emma C Schofield; John R Hodges; Thomas H Bak; John H Xuereb; Glenda M Halliday
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

2.  An autopsy confirmed case of progressive supranuclear palsy with predominant cerebellar ataxia.

Authors:  Myung Jun Lee; Jeong Hee Lee; Baik-Kyun Kim; Jae-Hyeok Lee; Young Min Lee; Seong-Jang Kim; Jin-Hong Shin; Myung-Jun Shin; Jae Woo Ahn; Suk Sung; Kyung-Un Choi; Dae Soo Jung; Na-Yeon Jung; William W Seeley; Gi Yeong Huh; Eun-Joo Kim
Journal:  J Neurol       Date:  2016-10-19       Impact factor: 4.849

3.  Track density imaging in progressive supranuclear palsy: A pilot study.

Authors:  Salvatore Nigro; Maria Giovanna Bianco; Gennarina Arabia; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Maria Salsone; Antonio Augimeri; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2018-11-26       Impact factor: 5.038

4.  Directed progression brain networks in Alzheimer's disease: properties and classification.

Authors:  Eric J Friedman; Karl Young; Danial Asif; Inderjit Jutla; Michael Liang; Scott Wilson; Adam S Landsberg; Norbert Schuff
Journal:  Brain Connect       Date:  2014-06

5.  Behavioural and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders.

Authors:  Biba R Stanton; P Nigel Leigh; Robert J Howard; Gareth J Barker; Richard G Brown
Journal:  J Neurol       Date:  2013-06-23       Impact factor: 4.849

6.  [18 F]AV-1451 tau positron emission tomography in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Val J Lowe; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  Mov Disord       Date:  2016-10-27       Impact factor: 10.338

Review 7.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

8.  Intrinsic connectivity network disruption in progressive supranuclear palsy.

Authors:  Raquel C Gardner; Adam L Boxer; Andrew Trujillo; Jacob B Mirsky; Christine C Guo; Efstathios D Gennatas; Hilary W Heuer; Eric Fine; Juan Zhou; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Ann Neurol       Date:  2013-03-27       Impact factor: 10.422

Review 9.  Voxelwise meta-analysis of white matter abnormalities in progressive supranuclear palsy.

Authors:  Jing Yang; Na Shao; Jianpeng Li; Huifang Shang
Journal:  Neurol Sci       Date:  2013-08-03       Impact factor: 3.307

10.  Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.

Authors:  Milica Jecmenica-Lukic; Igor N Petrovic; Tatjana Pekmezovic; Vladimir S Kostic
Journal:  J Neurol       Date:  2014-06-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.